BPC-157 reversed serotonin syndrome symptoms (hyperthermia, tremor, agitation) in rats, demonstrating anti-serotonin-toxicity effects alongside its known dopamine and GABA system interactions.
Key findingBPC-157 effectively counteracted serotonin syndrome signs (hyperthermia, tremor, rigidity, agitation) induced by multiple serotonergic drugs in rats,
What the researchers found
BPC-157 effectively counteracted serotonin syndrome signs (hyperthermia, tremor, rigidity, agitation) induced by multiple serotonergic drugs in rats, demonstrating serotonergic system modulation complementing its known dopaminergic and GABAergic interactions.
Why it matters
Relevant for bpc-157, anxiety-mood, neuroprotection.
How the study worked
animal-study study on bpc-157, anxiety-mood.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide research with translational implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
European journal of pharmacology, 512(2-3), 173-9
Citation
Boban Blagaic, Alenka; Blagaic, Vladimir; Mirt, Mirela; Jelovac, Nikola; Dodig, Goran; Rucman, Rudolf; Petek, Marijan; Turkovic, Branko; Anic, Tomislav; Dubovecak, Miroslav; Staresinic, Mario; Seiwerth, Sven; Sikiric, Predrag. (2005). Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.. European journal of pharmacology, 512(2-3), 173-9.